Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,102 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Active, Not Recruiting

Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia

NCT04150887

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

NCT04801797

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • University of California - Davis Sacramento, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

NCT06384261

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Health - Anschutz Cancer Pavilion - Anschutz Medical Campus Aurora, Colorado, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

NCT04217278

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospitals Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 14 locations
View Trial Details

Related conditions